We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WIRE
876
DELISTED
Encore Wire Corp
WIRE
| $386K | ﹤0.01% |
10,183
-15,862
| -61% | -$546K |
|
|
SRSC
877
DELISTED
SEARS Canada Inc.
SRSC
| $385K | ﹤0.01% |
41,583
-22,817
| -35% | -$222K |
|
878
HF Sinclair
DINO
$15B
| $383K | ﹤0.01% |
9,500
-4,162
| -30% | -$160K |
|
879
Quad
QUAD
$510M
| $381K | ﹤0.01% |
16,600
+3,801
| +30% | +$84.2K |
|
|
ALTR
880
DELISTED
Altera Corp
ALTR
| $378K | ﹤0.01% |
+8,817
| New | +$315K |
|
|
TIVO
881
DELISTED
Tivo Inc
TIVO
| $372K | ﹤0.01% |
20,422
-87,785
| -81% | -$1.96M |
|
882
Iron Mountain
IRM
$36.2B
| $365K | ﹤0.01% |
+10,000
| New | +$386K |
|
883
QuinStreet
QNST
$1.21B
| $358K | ﹤0.01% |
60,123
-54,758
| -48% | -$335K |
|
|
SWI
884
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $354K | ﹤0.01% |
+6,900
| New | +$343K |
|
885
Albemarle
ALB
$15.5B
| $353K | ﹤0.01% |
6,680
-103,330
| -94% | -$5.64M |
|
|
DTSI
886
DELISTED
DTS, Inc.
DTSI
| $351K | ﹤0.01% |
+10,300
| New | +$315K |
|
|
AVIV
887
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
| $350K | ﹤0.01% |
+9,588
| New | +$355K |
|
888
ePlus
PLUS
$2.37B
| $348K | ﹤0.01% |
+16,000
| New | +$311K |
|
|
SWIR
889
DELISTED
Sierra Wireless
SWIR
| $347K | ﹤0.01% |
+10,468
| New | +$393K |
|
|
TYC
890
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $344K | ﹤0.01% |
7,628
| – | – |
|
|
WMGI
891
DELISTED
Wright Medical Group Inc
WMGI
| $343K | ﹤0.01% |
13,300
+1,498
| +13% | +$38.6K |
|
|
AOI
892
DELISTED
Alliance One International
AOI
| $341K | ﹤0.01% |
31,035
-16,708
| -35% | -$188K |
|
|
QGENF
893
DELISTED
QIAGEN NV
QGENF
| $340K | ﹤0.01% |
13,500
-499,093
| -97% | -$12.6M |
|
|
SYNT
894
DELISTED
Syntel Inc
SYNT
| $337K | ﹤0.01% |
+6,521
| New | +$310K |
|
|
WILN
895
DELISTED
Wi-LAN Inc.
WILN
| $336K | ﹤0.01% |
136,475
-184,688
| -58% | -$509K |
|
|
SCHW
896
Charles Schwab
SCHW
$190B
| $332K | ﹤0.01% |
10,900
-120,216
| -92% | -$3.48M |
|
|
MITL
897
DELISTED
Mitel Networks Corporation
MITL
| $328K | ﹤0.01% |
32,270
-10,700
| -25% | -$107K |
|
898
O'Reilly Automotive
ORLY
$75.5B
| $326K | ﹤0.01% |
+22,590
| New | +$304K |
|
899
First Busey Corp
BUSE
$2.55B
| $322K | ﹤0.01% |
16,066
| – | – |
|
900
McGrath RentCorp
MGRC
$2.92B
| $317K | ﹤0.01% |
9,624
-3,700
| -28% | -$118K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.